Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is FIZE Medical's core product?
- FIZE Medical provides a platform technology to remotely monitor and manage patients with an indwelling Foley catheter. Their device, FIZE kUO, enables digital real-time measurement of kidney urine output and other health indicators, with customized alerts for clinical decision-making.
- When was FIZE Medical founded?
- FIZE Medical was founded in April 2020.
- What is the total amount of funding FIZE Medical has raised to date?
- FIZE Medical has raised a total of $45,870,000 USD in funding.
- Which investors participated in FIZE Medical's Series A funding rounds?
- Key investors in FIZE Medical's Series A rounds include Rapha Capital Management, Mendham Investment Group, White Hibiscus Capital, Valitas Ventures, and eHealth Ventures. For a full financing history, please refer to startupim.
- Has FIZE Medical's device received regulatory approval?
- Yes, FIZE Medical's device has been FDA registered and tested in clinical trials for efficacy and safety.
- What was a significant funding event for FIZE Medical in March 2026?
- In March 2026, FIZE Medical announced a $6 million warrant exercise, bringing their total Series A financing to $36 million.
- What distribution agreement did FIZE Medical announce in December 2025?
- In December 2025, FIZE Medical announced an exclusive distribution agreement with Asahi Kasei Medical for the launch of the FIZE kUO system in Japan.
- What strategic partnership did FIZE Medical secure in November 2025?
- In November 2025, FIZE Medical secured an investment and expanded its Israeli distribution through Eldan, a Neopharm Group company.
- Did FIZE Medical receive any grants?
- Yes, in February 2024, FIZE Medical received a $1,000,000 grant from the IIA.